[ad_1]
In what could be an important discovery for medicine, the project coordinators hope that the blood test can detect the presence of the virus in the first 24 hours after infection, before people show symptoms and a few days before a carrier. be considered capable of spreading it to other people. This problem would also mean around four days compared to current tests that can detect the virus.
The evidence appeared in a project established by the United States Defense Research Agency for Advanced Defense Projects (Darpa), which aims to quickly diagnose germs or poisonous chemical weapons. It started when the pandemic broke out and the new test is expected to be submitted for emergency approval (USA) by the United States Food and Drug Administration (FDA) within a week.
“The concept fills a global diagnostic gap,” Darpa chief biology officer Dr. Brad Ringeisen told the Guardian, adding that it should fill the gaps in testing in the later stages of infection. If given FDA approval, he said, the test could have the potential to be “an absolutely revolutionary product.”
For the most important news of the day, broadcast in real time and presented in an equidistant way, LIKE our Facebook page!
Follow Mediafax on Instagram for spectacular images and stories from around the world!
The content of the www.mediafax.ro website is exclusively for your personal information and use. is Prohibited republish the content of this site in the absence of a MEDIAFAX agreement. To obtain this agreement, contact us at [email protected].
[ad_2]